nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP3A4—Pimecrolimus—atopic dermatitis	0.104	0.182	CbGbCtD
Oxymorphone—CYP2D6—Loratadine—atopic dermatitis	0.0715	0.125	CbGbCtD
Oxymorphone—CYP2D6—Diphenhydramine—atopic dermatitis	0.0715	0.125	CbGbCtD
Oxymorphone—CYP3A4—Tacrolimus—atopic dermatitis	0.0621	0.108	CbGbCtD
Oxymorphone—CYP3A4—Loratadine—atopic dermatitis	0.0455	0.0794	CbGbCtD
Oxymorphone—CYP3A4—Methylprednisolone—atopic dermatitis	0.0416	0.0726	CbGbCtD
Oxymorphone—CYP3A4—Triamcinolone—atopic dermatitis	0.0315	0.055	CbGbCtD
Oxymorphone—CYP3A4—Betamethasone—atopic dermatitis	0.027	0.0472	CbGbCtD
Oxymorphone—CYP3A4—Prednisolone—atopic dermatitis	0.0267	0.0466	CbGbCtD
Oxymorphone—CYP3A4—Hydrocortisone—atopic dermatitis	0.0253	0.0442	CbGbCtD
Oxymorphone—CYP3A4—Prednisone—atopic dermatitis	0.0252	0.044	CbGbCtD
Oxymorphone—CYP2D6—Dexamethasone—atopic dermatitis	0.0247	0.0432	CbGbCtD
Oxymorphone—CYP3A4—Dexamethasone—atopic dermatitis	0.0157	0.0275	CbGbCtD
Oxymorphone—OPRM1—GPCR ligand binding—CCL22—atopic dermatitis	0.000417	0.00485	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000409	0.00476	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000397	0.00462	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000396	0.00461	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CCL17—atopic dermatitis	0.000395	0.00459	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000388	0.00452	CbGpPWpGaD
Oxymorphone—Body temperature increased—Tacrolimus—atopic dermatitis	0.000385	0.00113	CcSEcCtD
Oxymorphone—Headache—Mometasone—atopic dermatitis	0.000384	0.00112	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000382	0.00445	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000382	0.00445	CbGpPWpGaD
Oxymorphone—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000381	0.00112	CcSEcCtD
Oxymorphone—Eye disorder—Methylprednisolone—atopic dermatitis	0.000376	0.0011	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000375	0.00436	CbGpPWpGaD
Oxymorphone—Mental disorder—Hydrocortisone—atopic dermatitis	0.000375	0.0011	CcSEcCtD
Oxymorphone—OPRK1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000374	0.00436	CbGpPWpGaD
Oxymorphone—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000373	0.00109	CcSEcCtD
Oxymorphone—Malnutrition—Hydrocortisone—atopic dermatitis	0.000373	0.00109	CcSEcCtD
Oxymorphone—Bradycardia—Dexamethasone—atopic dermatitis	0.000372	0.00109	CcSEcCtD
Oxymorphone—Bradycardia—Betamethasone—atopic dermatitis	0.000372	0.00109	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.000372	0.00433	CbGpPWpGaD
Oxymorphone—Angiopathy—Methylprednisolone—atopic dermatitis	0.000365	0.00107	CcSEcCtD
Oxymorphone—Hallucination—Betamethasone—atopic dermatitis	0.000364	0.00107	CcSEcCtD
Oxymorphone—Hallucination—Dexamethasone—atopic dermatitis	0.000364	0.00107	CcSEcCtD
Oxymorphone—Nausea—Mometasone—atopic dermatitis	0.000364	0.00107	CcSEcCtD
Oxymorphone—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000363	0.00106	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—CCL11—atopic dermatitis	0.000363	0.00422	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.000362	0.00422	CbGpPWpGaD
Oxymorphone—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000362	0.00106	CcSEcCtD
Oxymorphone—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000362	0.00421	CbGpPWpGaD
Oxymorphone—Weight decreased—Prednisone—atopic dermatitis	0.00036	0.00105	CcSEcCtD
Oxymorphone—Vision blurred—Prednisolone—atopic dermatitis	0.000359	0.00105	CcSEcCtD
Oxymorphone—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000359	0.00105	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000359	0.00417	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000353	0.00411	CbGpPWpGaD
Oxymorphone—Visual impairment—Betamethasone—atopic dermatitis	0.000352	0.00103	CcSEcCtD
Oxymorphone—Visual impairment—Dexamethasone—atopic dermatitis	0.000352	0.00103	CcSEcCtD
Oxymorphone—Mental disorder—Methylprednisolone—atopic dermatitis	0.000352	0.00103	CcSEcCtD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000352	0.0041	CbGpPWpGaD
Oxymorphone—Malnutrition—Methylprednisolone—atopic dermatitis	0.00035	0.00103	CcSEcCtD
Oxymorphone—Asthenia—Tacrolimus—atopic dermatitis	0.00035	0.00102	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000347	0.00404	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000346	0.00403	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000346	0.00403	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000345	0.00402	CbGpPWpGaD
Oxymorphone—Pruritus—Tacrolimus—atopic dermatitis	0.000345	0.00101	CcSEcCtD
Oxymorphone—Vertigo—Prednisolone—atopic dermatitis	0.000343	0.001	CcSEcCtD
Oxymorphone—Syncope—Prednisolone—atopic dermatitis	0.000342	0.001	CcSEcCtD
Oxymorphone—Eye disorder—Betamethasone—atopic dermatitis	0.000342	0.001	CcSEcCtD
Oxymorphone—Eye disorder—Dexamethasone—atopic dermatitis	0.000342	0.001	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000341	0.00396	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000339	0.00395	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000336	0.00391	CbGpPWpGaD
Oxymorphone—Loss of consciousness—Prednisolone—atopic dermatitis	0.000335	0.000982	CcSEcCtD
Oxymorphone—Vertigo—Hydrocortisone—atopic dermatitis	0.000335	0.000981	CcSEcCtD
Oxymorphone—Syncope—Hydrocortisone—atopic dermatitis	0.000334	0.000979	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.000334	0.00388	CbGpPWpGaD
Oxymorphone—Diarrhoea—Tacrolimus—atopic dermatitis	0.000333	0.000977	CcSEcCtD
Oxymorphone—Angiopathy—Betamethasone—atopic dermatitis	0.000332	0.000972	CcSEcCtD
Oxymorphone—Angiopathy—Dexamethasone—atopic dermatitis	0.000332	0.000972	CcSEcCtD
Oxymorphone—Convulsion—Prednisolone—atopic dermatitis	0.00033	0.000968	CcSEcCtD
Oxymorphone—Hypertension—Prednisolone—atopic dermatitis	0.000329	0.000965	CcSEcCtD
Oxymorphone—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000327	0.000959	CcSEcCtD
Oxymorphone—Bradycardia—Prednisone—atopic dermatitis	0.000324	0.00095	CcSEcCtD
Oxymorphone—Convulsion—Hydrocortisone—atopic dermatitis	0.000323	0.000946	CcSEcCtD
Oxymorphone—Dizziness—Tacrolimus—atopic dermatitis	0.000322	0.000944	CcSEcCtD
Oxymorphone—Hypertension—Hydrocortisone—atopic dermatitis	0.000322	0.000942	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	0.000318	0.0037	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000317	0.00369	CbGpPWpGaD
Oxymorphone—Hallucination—Prednisone—atopic dermatitis	0.000317	0.000928	CcSEcCtD
Oxymorphone—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000316	0.00368	CbGpPWpGaD
Oxymorphone—Anxiety—Hydrocortisone—atopic dermatitis	0.000316	0.000926	CcSEcCtD
Oxymorphone—Vertigo—Triamcinolone—atopic dermatitis	0.000315	0.000923	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000315	0.000923	CcSEcCtD
Oxymorphone—Syncope—Triamcinolone—atopic dermatitis	0.000315	0.000922	CcSEcCtD
Oxymorphone—Vertigo—Methylprednisolone—atopic dermatitis	0.000314	0.000921	CcSEcCtD
Oxymorphone—Syncope—Methylprednisolone—atopic dermatitis	0.000314	0.00092	CcSEcCtD
Oxymorphone—Oedema—Prednisolone—atopic dermatitis	0.000311	0.000912	CcSEcCtD
Oxymorphone—Vomiting—Tacrolimus—atopic dermatitis	0.00031	0.000908	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000309	0.00359	CbGpPWpGaD
Oxymorphone—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000308	0.000903	CcSEcCtD
Oxymorphone—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000308	0.000901	CcSEcCtD
Oxymorphone—Dermatitis—Tacrolimus—atopic dermatitis	0.000307	0.0009	CcSEcCtD
Oxymorphone—Shock—Prednisolone—atopic dermatitis	0.000306	0.000897	CcSEcCtD
Oxymorphone—Headache—Tacrolimus—atopic dermatitis	0.000305	0.000895	CcSEcCtD
Oxymorphone—Oedema—Hydrocortisone—atopic dermatitis	0.000304	0.000891	CcSEcCtD
Oxymorphone—Convulsion—Triamcinolone—atopic dermatitis	0.000304	0.000891	CcSEcCtD
Oxymorphone—Tachycardia—Prednisolone—atopic dermatitis	0.000304	0.00089	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000304	0.00353	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000304	0.00353	CbGpPWpGaD
Oxymorphone—Convulsion—Methylprednisolone—atopic dermatitis	0.000303	0.000889	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000303	0.00353	CbGpPWpGaD
Oxymorphone—Hypertension—Triamcinolone—atopic dermatitis	0.000303	0.000887	CcSEcCtD
Oxymorphone—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000303	0.00352	CbGpPWpGaD
Oxymorphone—Hypertension—Methylprednisolone—atopic dermatitis	0.000302	0.000885	CcSEcCtD
Oxymorphone—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000301	0.000882	CcSEcCtD
Oxymorphone—Shock—Hydrocortisone—atopic dermatitis	0.000299	0.000877	CcSEcCtD
Oxymorphone—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000298	0.000874	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000298	0.00346	CbGpPWpGaD
Oxymorphone—Eye disorder—Prednisone—atopic dermatitis	0.000298	0.000872	CcSEcCtD
Oxymorphone—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000297	0.00346	CbGpPWpGaD
Oxymorphone—Anxiety—Methylprednisolone—atopic dermatitis	0.000297	0.00087	CcSEcCtD
Oxymorphone—Tachycardia—Hydrocortisone—atopic dermatitis	0.000297	0.00087	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000296	0.000867	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.000296	0.00344	CbGpPWpGaD
Oxymorphone—Flushing—Prednisone—atopic dermatitis	0.000295	0.000866	CcSEcCtD
Oxymorphone—Skin disorder—Hydrocortisone—atopic dermatitis	0.000295	0.000865	CcSEcCtD
Oxymorphone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000294	0.000861	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000294	0.00342	CbGpPWpGaD
Oxymorphone—Dry mouth—Triamcinolone—atopic dermatitis	0.000292	0.000856	CcSEcCtD
Oxymorphone—Anorexia—Hydrocortisone—atopic dermatitis	0.00029	0.000849	CcSEcCtD
Oxymorphone—Nausea—Tacrolimus—atopic dermatitis	0.000289	0.000848	CcSEcCtD
Oxymorphone—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.000289	0.00336	CbGpPWpGaD
Oxymorphone—Angiopathy—Prednisone—atopic dermatitis	0.000289	0.000847	CcSEcCtD
Oxymorphone—Confusional state—Methylprednisolone—atopic dermatitis	0.000288	0.000844	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000288	0.00335	CbGpPWpGaD
Oxymorphone—Immune system disorder—Prednisone—atopic dermatitis	0.000288	0.000843	CcSEcCtD
Oxymorphone—Oedema—Triamcinolone—atopic dermatitis	0.000286	0.000839	CcSEcCtD
Oxymorphone—Vertigo—Dexamethasone—atopic dermatitis	0.000286	0.000838	CcSEcCtD
Oxymorphone—Vertigo—Betamethasone—atopic dermatitis	0.000286	0.000838	CcSEcCtD
Oxymorphone—Syncope—Dexamethasone—atopic dermatitis	0.000285	0.000836	CcSEcCtD
Oxymorphone—Syncope—Betamethasone—atopic dermatitis	0.000285	0.000836	CcSEcCtD
Oxymorphone—Hypotension—Hydrocortisone—atopic dermatitis	0.000284	0.000832	CcSEcCtD
Oxymorphone—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000284	0.0033	CbGpPWpGaD
Oxymorphone—Shock—Triamcinolone—atopic dermatitis	0.000282	0.000825	CcSEcCtD
Oxymorphone—Insomnia—Prednisolone—atopic dermatitis	0.000282	0.000825	CcSEcCtD
Oxymorphone—Shock—Methylprednisolone—atopic dermatitis	0.000281	0.000823	CcSEcCtD
Oxymorphone—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00028	0.000821	CcSEcCtD
Oxymorphone—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00028	0.00082	CcSEcCtD
Oxymorphone—Loss of consciousness—Betamethasone—atopic dermatitis	0.00028	0.00082	CcSEcCtD
Oxymorphone—Tachycardia—Triamcinolone—atopic dermatitis	0.000279	0.000819	CcSEcCtD
Oxymorphone—Mental disorder—Prednisone—atopic dermatitis	0.000279	0.000817	CcSEcCtD
Oxymorphone—Tachycardia—Methylprednisolone—atopic dermatitis	0.000279	0.000817	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000278	0.00324	CbGpPWpGaD
Oxymorphone—Skin disorder—Methylprednisolone—atopic dermatitis	0.000277	0.000813	CcSEcCtD
Oxymorphone—Malnutrition—Prednisone—atopic dermatitis	0.000277	0.000812	CcSEcCtD
Oxymorphone—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000277	0.000811	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000276	0.000809	CcSEcCtD
Oxymorphone—Convulsion—Betamethasone—atopic dermatitis	0.000276	0.000808	CcSEcCtD
Oxymorphone—Convulsion—Dexamethasone—atopic dermatitis	0.000276	0.000808	CcSEcCtD
Oxymorphone—Insomnia—Hydrocortisone—atopic dermatitis	0.000275	0.000806	CcSEcCtD
Oxymorphone—Hypertension—Dexamethasone—atopic dermatitis	0.000275	0.000805	CcSEcCtD
Oxymorphone—Hypertension—Betamethasone—atopic dermatitis	0.000275	0.000805	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000274	0.00319	CbGpPWpGaD
Oxymorphone—Anxiety—Dexamethasone—atopic dermatitis	0.00027	0.000791	CcSEcCtD
Oxymorphone—Anxiety—Betamethasone—atopic dermatitis	0.00027	0.000791	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.000269	0.00313	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.000268	0.00312	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000268	0.00311	CbGpPWpGaD
Oxymorphone—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000268	0.000784	CcSEcCtD
Oxymorphone—Hypotension—Methylprednisolone—atopic dermatitis	0.000267	0.000782	CcSEcCtD
Oxymorphone—Pain—Prednisolone—atopic dermatitis	0.000266	0.00078	CcSEcCtD
Oxymorphone—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000264	0.000774	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.000264	0.00307	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.000264	0.00307	CbGpPWpGaD
Oxymorphone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000262	0.000769	CcSEcCtD
Oxymorphone—Fatigue—Hydrocortisone—atopic dermatitis	0.000262	0.000768	CcSEcCtD
Oxymorphone—Vision blurred—Prednisone—atopic dermatitis	0.000261	0.000765	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000261	0.00304	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000261	0.00303	CbGpPWpGaD
Oxymorphone—Pain—Hydrocortisone—atopic dermatitis	0.00026	0.000762	CcSEcCtD
Oxymorphone—Oedema—Betamethasone—atopic dermatitis	0.00026	0.000761	CcSEcCtD
Oxymorphone—Oedema—Dexamethasone—atopic dermatitis	0.00026	0.000761	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.000259	0.00302	CbGpPWpGaD
Oxymorphone—Insomnia—Triamcinolone—atopic dermatitis	0.000259	0.000759	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000259	0.00301	CbGpPWpGaD
Oxymorphone—Insomnia—Methylprednisolone—atopic dermatitis	0.000258	0.000757	CcSEcCtD
Oxymorphone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000258	0.003	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.000258	0.003	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000257	0.00298	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000257	0.00298	CbGpPWpGaD
Oxymorphone—Feeling abnormal—Prednisolone—atopic dermatitis	0.000257	0.000752	CcSEcCtD
Oxymorphone—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000256	0.00298	CbGpPWpGaD
Oxymorphone—Shock—Dexamethasone—atopic dermatitis	0.000256	0.000749	CcSEcCtD
Oxymorphone—Shock—Betamethasone—atopic dermatitis	0.000256	0.000749	CcSEcCtD
Oxymorphone—Dyspnoea—Triamcinolone—atopic dermatitis	0.000255	0.000748	CcSEcCtD
Oxymorphone—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000255	0.000746	CcSEcCtD
Oxymorphone—Nervous system disorder—Betamethasone—atopic dermatitis	0.000255	0.000746	CcSEcCtD
Oxymorphone—Agitation—Prednisone—atopic dermatitis	0.000255	0.000746	CcSEcCtD
Oxymorphone—Tachycardia—Betamethasone—atopic dermatitis	0.000254	0.000743	CcSEcCtD
Oxymorphone—Tachycardia—Dexamethasone—atopic dermatitis	0.000254	0.000743	CcSEcCtD
Oxymorphone—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.000253	0.00295	CbGpPWpGaD
Oxymorphone—Dyspepsia—Triamcinolone—atopic dermatitis	0.000252	0.000738	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000252	0.00293	CbGpPWpGaD
Oxymorphone—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000251	0.000737	CcSEcCtD
Oxymorphone—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000251	0.000736	CcSEcCtD
Oxymorphone—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000251	0.000736	CcSEcCtD
Oxymorphone—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000251	0.000734	CcSEcCtD
Oxymorphone—Vertigo—Prednisone—atopic dermatitis	0.000249	0.00073	CcSEcCtD
Oxymorphone—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000249	0.00289	CbGpPWpGaD
Oxymorphone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000249	0.000729	CcSEcCtD
Oxymorphone—Syncope—Prednisone—atopic dermatitis	0.000249	0.000728	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000248	0.00289	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000248	0.00288	CbGpPWpGaD
Oxymorphone—Anorexia—Betamethasone—atopic dermatitis	0.000248	0.000726	CcSEcCtD
Oxymorphone—Anorexia—Dexamethasone—atopic dermatitis	0.000248	0.000726	CcSEcCtD
Oxymorphone—Urticaria—Prednisolone—atopic dermatitis	0.000247	0.000725	CcSEcCtD
Oxymorphone—Fatigue—Triamcinolone—atopic dermatitis	0.000247	0.000723	CcSEcCtD
Oxymorphone—Fatigue—Methylprednisolone—atopic dermatitis	0.000246	0.000722	CcSEcCtD
Oxymorphone—Pain—Triamcinolone—atopic dermatitis	0.000245	0.000717	CcSEcCtD
Oxymorphone—Loss of consciousness—Prednisone—atopic dermatitis	0.000244	0.000714	CcSEcCtD
Oxymorphone—Hypotension—Betamethasone—atopic dermatitis	0.000243	0.000711	CcSEcCtD
Oxymorphone—Hypotension—Dexamethasone—atopic dermatitis	0.000243	0.000711	CcSEcCtD
Oxymorphone—Urticaria—Hydrocortisone—atopic dermatitis	0.000242	0.000708	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000241	0.0028	CbGpPWpGaD
Oxymorphone—Body temperature increased—Hydrocortisone—atopic dermatitis	0.00024	0.000704	CcSEcCtD
Oxymorphone—Abdominal pain—Hydrocortisone—atopic dermatitis	0.00024	0.000704	CcSEcCtD
Oxymorphone—Convulsion—Prednisone—atopic dermatitis	0.00024	0.000704	CcSEcCtD
Oxymorphone—Hypertension—Prednisone—atopic dermatitis	0.000239	0.000701	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000236	0.00275	CbGpPWpGaD
Oxymorphone—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000236	0.000691	CcSEcCtD
Oxymorphone—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000235	0.00069	CcSEcCtD
Oxymorphone—Anxiety—Prednisone—atopic dermatitis	0.000235	0.000689	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000235	0.00274	CbGpPWpGaD
Oxymorphone—Insomnia—Betamethasone—atopic dermatitis	0.000235	0.000688	CcSEcCtD
Oxymorphone—Insomnia—Dexamethasone—atopic dermatitis	0.000235	0.000688	CcSEcCtD
Oxymorphone—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000235	0.00273	CbGpPWpGaD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000234	0.000687	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000234	0.000684	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.000231	0.00269	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.000231	0.00269	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.000231	0.00269	CbGpPWpGaD
Oxymorphone—Hypersensitivity—Prednisolone—atopic dermatitis	0.000229	0.000672	CcSEcCtD
Oxymorphone—Dyspepsia—Dexamethasone—atopic dermatitis	0.000229	0.00067	CcSEcCtD
Oxymorphone—Dyspepsia—Betamethasone—atopic dermatitis	0.000229	0.00067	CcSEcCtD
Oxymorphone—Urticaria—Triamcinolone—atopic dermatitis	0.000227	0.000666	CcSEcCtD
Oxymorphone—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000227	0.00264	CbGpPWpGaD
Oxymorphone—Urticaria—Methylprednisolone—atopic dermatitis	0.000227	0.000665	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000227	0.00264	CbGpPWpGaD
Oxymorphone—Body temperature increased—Triamcinolone—atopic dermatitis	0.000226	0.000663	CcSEcCtD
Oxymorphone—Oedema—Prednisone—atopic dermatitis	0.000226	0.000663	CcSEcCtD
Oxymorphone—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.000226	0.00263	CbGpPWpGaD
Oxymorphone—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000226	0.000662	CcSEcCtD
Oxymorphone—Decreased appetite—Dexamethasone—atopic dermatitis	0.000226	0.000662	CcSEcCtD
Oxymorphone—Decreased appetite—Betamethasone—atopic dermatitis	0.000226	0.000662	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000224	0.000657	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000224	0.000657	CcSEcCtD
Oxymorphone—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000224	0.000656	CcSEcCtD
Oxymorphone—Fatigue—Dexamethasone—atopic dermatitis	0.000224	0.000656	CcSEcCtD
Oxymorphone—Fatigue—Betamethasone—atopic dermatitis	0.000224	0.000656	CcSEcCtD
Oxymorphone—Shock—Prednisone—atopic dermatitis	0.000223	0.000652	CcSEcCtD
Oxymorphone—Pain—Betamethasone—atopic dermatitis	0.000222	0.000651	CcSEcCtD
Oxymorphone—Pain—Dexamethasone—atopic dermatitis	0.000222	0.000651	CcSEcCtD
Oxymorphone—Nervous system disorder—Prednisone—atopic dermatitis	0.000222	0.00065	CcSEcCtD
Oxymorphone—Tachycardia—Prednisone—atopic dermatitis	0.000221	0.000647	CcSEcCtD
Oxymorphone—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00022	0.00256	CbGpPWpGaD
Oxymorphone—Skin disorder—Prednisone—atopic dermatitis	0.00022	0.000644	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000219	0.00255	CbGpPWpGaD
Oxymorphone—Hyperhidrosis—Prednisone—atopic dermatitis	0.000219	0.000641	CcSEcCtD
Oxymorphone—Asthenia—Hydrocortisone—atopic dermatitis	0.000218	0.000639	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000218	0.00253	CbGpPWpGaD
Oxymorphone—Anorexia—Prednisone—atopic dermatitis	0.000216	0.000632	CcSEcCtD
Oxymorphone—Pruritus—Hydrocortisone—atopic dermatitis	0.000215	0.00063	CcSEcCtD
Oxymorphone—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.000214	0.00249	CbGpPWpGaD
Oxymorphone—Feeling abnormal—Betamethasone—atopic dermatitis	0.000214	0.000627	CcSEcCtD
Oxymorphone—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000214	0.000627	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000213	0.00248	CbGpPWpGaD
Oxymorphone—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000212	0.000622	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000212	0.000622	CcSEcCtD
Oxymorphone—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000211	0.000618	CcSEcCtD
Oxymorphone—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.00021	0.000617	CcSEcCtD
Oxymorphone—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00021	0.00245	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000209	0.00243	CbGpPWpGaD
Oxymorphone—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000208	0.00061	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000207	0.00241	CbGpPWpGaD
Oxymorphone—Urticaria—Betamethasone—atopic dermatitis	0.000206	0.000605	CcSEcCtD
Oxymorphone—Urticaria—Dexamethasone—atopic dermatitis	0.000206	0.000605	CcSEcCtD
Oxymorphone—Dizziness—Prednisolone—atopic dermatitis	0.000206	0.000603	CcSEcCtD
Oxymorphone—Asthenia—Triamcinolone—atopic dermatitis	0.000205	0.000602	CcSEcCtD
Oxymorphone—Body temperature increased—Dexamethasone—atopic dermatitis	0.000205	0.000602	CcSEcCtD
Oxymorphone—Body temperature increased—Betamethasone—atopic dermatitis	0.000205	0.000602	CcSEcCtD
Oxymorphone—Abdominal pain—Betamethasone—atopic dermatitis	0.000205	0.000602	CcSEcCtD
Oxymorphone—Abdominal pain—Dexamethasone—atopic dermatitis	0.000205	0.000602	CcSEcCtD
Oxymorphone—Asthenia—Methylprednisolone—atopic dermatitis	0.000205	0.000601	CcSEcCtD
Oxymorphone—Insomnia—Prednisone—atopic dermatitis	0.000205	0.0006	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000203	0.00237	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.000203	0.00236	CbGpPWpGaD
Oxymorphone—Pruritus—Triamcinolone—atopic dermatitis	0.000203	0.000594	CcSEcCtD
Oxymorphone—Pruritus—Methylprednisolone—atopic dermatitis	0.000202	0.000592	CcSEcCtD
Oxymorphone—Dizziness—Hydrocortisone—atopic dermatitis	0.000201	0.000589	CcSEcCtD
Oxymorphone—Dyspepsia—Prednisone—atopic dermatitis	0.000199	0.000583	CcSEcCtD
Oxymorphone—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000198	0.00231	CbGpPWpGaD
Oxymorphone—Decreased appetite—Prednisone—atopic dermatitis	0.000197	0.000576	CcSEcCtD
Oxymorphone—Dermatitis—Prednisolone—atopic dermatitis	0.000196	0.000575	CcSEcCtD
Oxymorphone—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000195	0.000573	CcSEcCtD
Oxymorphone—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000195	0.00227	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000195	0.00227	CbGpPWpGaD
Oxymorphone—Fatigue—Prednisone—atopic dermatitis	0.000195	0.000571	CcSEcCtD
Oxymorphone—Headache—Prednisolone—atopic dermatitis	0.000195	0.000571	CcSEcCtD
Oxymorphone—Constipation—Prednisone—atopic dermatitis	0.000193	0.000567	CcSEcCtD
Oxymorphone—Vomiting—Hydrocortisone—atopic dermatitis	0.000193	0.000566	CcSEcCtD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000192	0.00223	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000192	0.00223	CbGpPWpGaD
Oxymorphone—Dermatitis—Hydrocortisone—atopic dermatitis	0.000192	0.000561	CcSEcCtD
Oxymorphone—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.000191	0.00222	CbGpPWpGaD
Oxymorphone—Headache—Hydrocortisone—atopic dermatitis	0.00019	0.000558	CcSEcCtD
Oxymorphone—Dizziness—Triamcinolone—atopic dermatitis	0.000189	0.000555	CcSEcCtD
Oxymorphone—Dizziness—Methylprednisolone—atopic dermatitis	0.000189	0.000553	CcSEcCtD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000187	0.00217	CbGpPWpGaD
Oxymorphone—Feeling abnormal—Prednisone—atopic dermatitis	0.000186	0.000546	CcSEcCtD
Oxymorphone—Asthenia—Dexamethasone—atopic dermatitis	0.000186	0.000546	CcSEcCtD
Oxymorphone—Asthenia—Betamethasone—atopic dermatitis	0.000186	0.000546	CcSEcCtD
Oxymorphone—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	0.000186	0.00217	CbGpPWpGaD
Oxymorphone—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000185	0.000542	CcSEcCtD
Oxymorphone—Nausea—Prednisolone—atopic dermatitis	0.000185	0.000542	CcSEcCtD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000184	0.00214	CbGpPWpGaD
Oxymorphone—Pruritus—Dexamethasone—atopic dermatitis	0.000184	0.000539	CcSEcCtD
Oxymorphone—Pruritus—Betamethasone—atopic dermatitis	0.000184	0.000539	CcSEcCtD
Oxymorphone—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	0.000184	0.00214	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000183	0.00213	CbGpPWpGaD
Oxymorphone—Vomiting—Triamcinolone—atopic dermatitis	0.000182	0.000533	CcSEcCtD
Oxymorphone—Vomiting—Methylprednisolone—atopic dermatitis	0.000182	0.000532	CcSEcCtD
Oxymorphone—Nausea—Hydrocortisone—atopic dermatitis	0.000181	0.000529	CcSEcCtD
Oxymorphone—Dermatitis—Triamcinolone—atopic dermatitis	0.00018	0.000528	CcSEcCtD
Oxymorphone—Dermatitis—Methylprednisolone—atopic dermatitis	0.00018	0.000527	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	0.00018	0.00209	CbGpPWpGaD
Oxymorphone—Urticaria—Prednisone—atopic dermatitis	0.00018	0.000527	CcSEcCtD
Oxymorphone—Headache—Triamcinolone—atopic dermatitis	0.000179	0.000526	CcSEcCtD
Oxymorphone—Headache—Methylprednisolone—atopic dermatitis	0.000179	0.000524	CcSEcCtD
Oxymorphone—Abdominal pain—Prednisone—atopic dermatitis	0.000179	0.000524	CcSEcCtD
Oxymorphone—Body temperature increased—Prednisone—atopic dermatitis	0.000179	0.000524	CcSEcCtD
Oxymorphone—Diarrhoea—Dexamethasone—atopic dermatitis	0.000178	0.000521	CcSEcCtD
Oxymorphone—Diarrhoea—Betamethasone—atopic dermatitis	0.000178	0.000521	CcSEcCtD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000175	0.00204	CbGpPWpGaD
Oxymorphone—Dizziness—Dexamethasone—atopic dermatitis	0.000172	0.000503	CcSEcCtD
Oxymorphone—Dizziness—Betamethasone—atopic dermatitis	0.000172	0.000503	CcSEcCtD
Oxymorphone—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.000171	0.00199	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	0.000171	0.00199	CbGpPWpGaD
Oxymorphone—Nausea—Triamcinolone—atopic dermatitis	0.00017	0.000498	CcSEcCtD
Oxymorphone—Nausea—Methylprednisolone—atopic dermatitis	0.00017	0.000497	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000168	0.00196	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000167	0.00194	CbGpPWpGaD
Oxymorphone—Hypersensitivity—Prednisone—atopic dermatitis	0.000167	0.000488	CcSEcCtD
Oxymorphone—Vomiting—Dexamethasone—atopic dermatitis	0.000165	0.000484	CcSEcCtD
Oxymorphone—Vomiting—Betamethasone—atopic dermatitis	0.000165	0.000484	CcSEcCtD
Oxymorphone—Dermatitis—Dexamethasone—atopic dermatitis	0.000164	0.000479	CcSEcCtD
Oxymorphone—Dermatitis—Betamethasone—atopic dermatitis	0.000164	0.000479	CcSEcCtD
Oxymorphone—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	0.000163	0.0019	CbGpPWpGaD
Oxymorphone—Headache—Betamethasone—atopic dermatitis	0.000163	0.000477	CcSEcCtD
Oxymorphone—Headache—Dexamethasone—atopic dermatitis	0.000163	0.000477	CcSEcCtD
Oxymorphone—Asthenia—Prednisone—atopic dermatitis	0.000162	0.000476	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	0.000162	0.00189	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000162	0.00188	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	0.000161	0.00187	CbGpPWpGaD
Oxymorphone—Pruritus—Prednisone—atopic dermatitis	0.00016	0.000469	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	0.000158	0.00184	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000158	0.00183	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000155	0.0018	CbGpPWpGaD
Oxymorphone—Diarrhoea—Prednisone—atopic dermatitis	0.000155	0.000454	CcSEcCtD
Oxymorphone—Nausea—Dexamethasone—atopic dermatitis	0.000154	0.000452	CcSEcCtD
Oxymorphone—Nausea—Betamethasone—atopic dermatitis	0.000154	0.000452	CcSEcCtD
Oxymorphone—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	0.000152	0.00177	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.000152	0.00177	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	0.00015	0.00174	CbGpPWpGaD
Oxymorphone—Dizziness—Prednisone—atopic dermatitis	0.00015	0.000438	CcSEcCtD
Oxymorphone—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.000149	0.00173	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000149	0.00173	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000147	0.00171	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000146	0.0017	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000145	0.00169	CbGpPWpGaD
Oxymorphone—Vomiting—Prednisone—atopic dermatitis	0.000144	0.000421	CcSEcCtD
Oxymorphone—Dermatitis—Prednisone—atopic dermatitis	0.000142	0.000418	CcSEcCtD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000142	0.00165	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	0.000142	0.00165	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000142	0.00165	CbGpPWpGaD
Oxymorphone—Headache—Prednisone—atopic dermatitis	0.000142	0.000415	CcSEcCtD
Oxymorphone—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.000138	0.00161	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.000138	0.00161	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	0.000136	0.00159	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.000136	0.00158	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	0.000135	0.00157	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.000135	0.00157	CbGpPWpGaD
Oxymorphone—Nausea—Prednisone—atopic dermatitis	0.000134	0.000394	CcSEcCtD
Oxymorphone—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	0.000133	0.00155	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.000133	0.00155	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	0.000133	0.00155	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000133	0.00154	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	0.000131	0.00152	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000131	0.00152	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000129	0.0015	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000128	0.00149	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.000126	0.00147	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	0.000126	0.00146	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000124	0.00144	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	0.000122	0.00141	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	0.000121	0.00141	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	0.00012	0.0014	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00012	0.0014	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	0.00012	0.00139	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	0.000119	0.00138	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	0.000119	0.00138	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000118	0.00137	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000116	0.00135	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000113	0.00131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	0.000113	0.00131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	0.000112	0.00131	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00011	0.00128	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	0.00011	0.00128	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	0.00011	0.00128	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	0.00011	0.00128	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	0.00011	0.00128	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000108	0.00126	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000107	0.00125	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	0.000107	0.00124	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000104	0.0012	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	0.000103	0.0012	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	0.000103	0.00119	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000102	0.00118	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	0.000101	0.00118	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	0.0001	0.00117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	0.0001	0.00117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	9.83e-05	0.00114	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	9.8e-05	0.00114	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	9.64e-05	0.00112	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	9.64e-05	0.00112	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.53e-05	0.00111	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	9.4e-05	0.00109	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	9.32e-05	0.00108	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	9.23e-05	0.00107	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	9.16e-05	0.00107	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	9.07e-05	0.00105	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	9.01e-05	0.00105	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	8.97e-05	0.00104	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	8.91e-05	0.00104	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	8.75e-05	0.00102	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	8.59e-05	0.000999	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	8.32e-05	0.000968	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	8.15e-05	0.000948	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	8.15e-05	0.000948	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	8.09e-05	0.000942	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	8.03e-05	0.000934	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NPS—atopic dermatitis	7.99e-05	0.00093	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	7.99e-05	0.00093	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	7.95e-05	0.000925	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	7.86e-05	0.000915	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	7.84e-05	0.000912	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	7.66e-05	0.000892	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	7.53e-05	0.000876	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL5—atopic dermatitis	7.43e-05	0.000864	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	7.29e-05	0.000848	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	7.26e-05	0.000845	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NPS—atopic dermatitis	7.01e-05	0.000815	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	7.01e-05	0.000815	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	6.87e-05	0.000799	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	6.84e-05	0.000796	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	6.79e-05	0.00079	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	6.64e-05	0.000773	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL5—atopic dermatitis	6.51e-05	0.000758	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	6.33e-05	0.000737	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	6.16e-05	0.000717	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NPS—atopic dermatitis	5.92e-05	0.000689	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	5.92e-05	0.000689	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	5.81e-05	0.000676	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GLB1—atopic dermatitis	5.69e-05	0.000662	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	5.55e-05	0.000646	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.54e-05	0.000644	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL5—atopic dermatitis	5.51e-05	0.000641	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	5.45e-05	0.000634	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ADSL—atopic dermatitis	5.45e-05	0.000634	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	5.29e-05	0.000616	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NGF—atopic dermatitis	5.05e-05	0.000588	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	5.03e-05	0.000585	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	4.91e-05	0.000572	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.85e-05	0.000565	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	4.8e-05	0.000559	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	4.78e-05	0.000556	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	4.69e-05	0.000546	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	4.64e-05	0.00054	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NGF—atopic dermatitis	4.43e-05	0.000515	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	4.41e-05	0.000513	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	4.31e-05	0.000501	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	4.21e-05	0.00049	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	4.16e-05	0.000485	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.1e-05	0.000477	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	4.04e-05	0.00047	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	3.92e-05	0.000456	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NGF—atopic dermatitis	3.74e-05	0.000435	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	3.73e-05	0.000433	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.72e-05	0.000433	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	3.65e-05	0.000425	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	3.64e-05	0.000424	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.56e-05	0.000415	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	3.56e-05	0.000414	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	3.09e-05	0.000359	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	2.97e-05	0.000346	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL2—atopic dermatitis	2.84e-05	0.00033	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	2.82e-05	0.000329	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.61e-05	0.000304	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	2.6e-05	0.000303	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL2—atopic dermatitis	2.49e-05	0.00029	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	2.48e-05	0.000288	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	2.29e-05	0.000267	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.2e-05	0.000256	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2—atopic dermatitis	2.1e-05	0.000245	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	2.09e-05	0.000244	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.94e-05	0.000225	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.85e-05	0.000215	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—atopic dermatitis	1.67e-05	0.000194	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—atopic dermatitis	1.46e-05	0.00017	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—atopic dermatitis	1.24e-05	0.000144	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.21e-05	0.00014	CbGpPWpGaD
